Deciphering the Therapeutic Potential of Novel Pentyloxyamide-Based Class I, IIb HDAC Inhibitors against Therapy-Resistant Leukemia.
Journal of medicinal chemistry
View this publicationJournal of medicinal chemistry
View this publicationPediatric radiology
View this publicationInternational journal of molecular sciences
View this publicationDiagnostics (Basel, Switzerland)
View this publicationCommunications biology
View this publicationCell chemical biology
View this publicationHemaSphere
View this publicationInvestigative radiology
View this publicationCell reports. Medicine
View this publicationBritish journal of pharmacology
View this publication